Answer
Oct 17, 2024 - 10:22 AM
Incruse Ellipta, which contains the active ingredient umeclidinium, is a long-acting muscarinic antagonist (LAMA) used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). Each dose is designed to provide 24-hour bronchodilation, so it is typically taken once daily. It's important to follow your healthcare provider's instructions regarding dosage and frequency.
